Dynacaz 30 mg MR


Modified release tablets.
scheduling status
S3
registration number
42/21.2/0249
What Dynacaz 30 mg MR contains
Gliclazide 30 mg.
other ingredients
Calcium carbonate Colloidal silica dioxide Hypromellose Lactose monohydrate Magnesium stearate.
Therapeutic classification
A10BB09. A 21.2 Oral Hypoglycaemics.
© 2026 SAHPRA. ALL RIGHTS RESERVED